Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

This publication has 27 references indexed in Scilit:

• Introduction
  American Journal of Obstetrics and Gynecology, 1998
• Molecular Biology and Pathophysiology of APC Resistance: Current Insights and Clinical Implications
  Seminars in Thrombosis and Hemostasis, 1998
• Oral contraceptives and venous thromboembolism
  The Lancet, 1997
• End of the line for “third-generation-pill” controversy?
  The Lancet, 1997
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals
  Blood Coagulation & Fibrinolysis, 1997
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Oral Contraceptives and Cardiovascular Disease
  New England Journal of Medicine, 1981